Why 6% yielder Standard Life Aberdeen plc isn’t the only dividend stock I’d consider today

Standard Life Aberdeen plc (LON:SLA) has had a disappointing start, but Roland Head believes the outlook is improving.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Shares of small-cap financial services firm STM Group (LSE: STM) rose by more than 6% on Tuesday after the company issued its final results for 2017.

The company, which specialises in providing pension and wealth management services for Britons living abroad, said that revenue rose by 24% to £21.5m last year. Underlying pre-tax profit rose by 39% to £3.2m, while underlying earnings rose by 68% to 5.29p per share.

Cash and cash equivalents held on the group’s balance sheet rose by 55% to £18.4m, while the final dividend will rise by 20% to 1.2p per share. This gives a total payout for the year of 1.8p per share.

An eventful year

2017 was a difficult year for the firm. Tax changes in the government’s Spring Budget meant that the firm’s overseas pension business took a big hit, losing an estimated 80% of new sales of its ‘QROPS’ product.

To accommodate these changes, the company launched a new international pension product, the International SIPP. In today’s results, STM said that sales of this new offering have replaced most of the lost QROPS business by “both policy number and revenue”.

The firm is also continuing to expand its life assurance business, where revenue rose from £2.8m to £5.8m in 2017.

In my opinion, this company seems to be adapting well to changing market conditions. STM’s strong cash balance also gives the firm some breathing room and could provide funding for further acquisitions.

STM shares now trade on around 9.5 times 2018 forecast earnings, with a forecast yield of 3.5%. I believe this could be of interest to long-term investors.

Don’t give up too quickly

When Standard Life and Aberdeen Asset Management announced plans to merge and form Standard Life Aberdeen (LSE: SLA), hopes were high that the group would deliver bigger profits at a lower cost. So far the evidence has been mixed.

The group’s shares have fallen by about 15% since the merger completed last summer. Although assets under management and administration ended 2017 up by 1%, at £654.9bn, we learned recently that Lloyds Banking Group will withdraw approximately £109bn of assets under management from the group, subject to a 12-month notice period.

According to the firm, the Lloyds assets represented “less than 5%” of the combined firm’s 2017 revenue. Cost-cutting should reduce the impact on profits, but analysts’ consensus forecasts for 2019 have still been cut by 8% since this news was released.

Despite this, many large deals have teething problems. I think it’s too soon to write off this FTSE 100 firm. Indeed, my view is that it’s starting to look like a possible contrarian buy.

Is this 6% yield safe?

Standard Life Aberdeen’s falling share price has left the stock with a 2018 forecast P/E rating of 12, and a potential yield of 6.4%.

Although dividend cover is now quite slim, at just 1.3 times earnings, I think this valuation is starting to look quite tempting.

Analysts forecasting a 1% increase in earnings per share for 2018, with a 6% increase in 2019. Investors expecting fireworks should probably look elsewhere, but I think the group’s strong cash generation means that a dividend cut is unlikely.

Indeed, I believe the shares are starting to shape up as a potential long-term buy for income investors. I’d consider opening a starter position at current levels.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Roland Head has no position in any of the shares mentioned. The Motley Fool UK has recommended Lloyds Banking Group and Standard Life Aberdeen. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

After it crashed 25%, should I buy this former stock market darling in my Stocks and Shares ISA?

Harvey Jones has a big hole in his Stocks and Shares ISA that he is keen to fill. Should he…

Read more »

happy senior couple using a laptop in their living room to look at their financial budgets
Investing Articles

How’s the dividend forecast looking for Legal & General shares in 2025 and beyond?

As a shareholder, I like to keep track of the potential dividend returns I could make from my Legal &…

Read more »

artificial intelligence investing algorithms
Investing Articles

Could buying this stock with a $7bn market cap be like investing in Nvidia in 2010?

Where might the next Nvidia-type stock be lurking in today's market? Our writer takes a look at one candidate with…

Read more »

Investing Articles

Is GSK a bargain now the share price is near 1,333p?

Biopharma company GSK looks like a decent stock to consider for the long term, so is today's lower share price…

Read more »

Snowing on Jubilee Gardens in London at dusk
Investing Articles

Could December be a great month to buy UK shares?

Christopher Ruane sees some possible reasons to look for shares to buy in December -- but he'll be using the…

Read more »

Young mixed-race couple sat on the beach looking out over the sea
Investing Articles

Sticking to FTSE shares, I’d still aim for a £1,000 monthly passive income like this!

By investing in blue-chip FTSE shares with proven business models, our writer hopes he can build sizeable passive income streams…

Read more »

Growth Shares

BT shares? I think there are much better UK stocks for the long term

Over the long term, many UK stocks have performed much better than BT. Here’s a look at two companies that…

Read more »

British Pennies on a Pound Note
Investing Articles

After a 540% rise, could this penny share keep going?

This penny share has seen mixed fortunes in recent years. Our writer looks ahead to some potentially exciting developments in…

Read more »